Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sharp

Showing results (361-370 of 487) with videos related to

Pageof 49
Sort By:
JACC. Cardiovascular Interventions|December 28, 2020
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal DenervationMichel Azizi, Joost Daemen, Melvin D Lobo, et al.
JACC. Cardiovascular Interventions|July 20, 2019
Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back DataChristopher M Cook, Takayuki Warisawa, James P Howard, et al.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
Nature|June 3, 2026
Nuclear shell structure governs short-range nucleon pairingD Nguyen, C Yero, H Szumila-Vance, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
Circulation|May 24, 2018
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery DiseaseRasha Al-Lamee, James P Howard, Matthew J Shun-Shin, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
European Heart Journal|March 27, 2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapiesFelix Mahfoud, Michel Azizi, Sebastian Ewen, et al.
Circulation|September 12, 2024
Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research CollaborativeKenneth Rosenfield, Terry R Bowers, Christopher F Barnett, et al.
Pageof 49

Showing results (361-370 of 487) with videos related to

Sort By:
Pageof 49
JACC. Cardiovascular Interventions|December 28, 2020
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal DenervationMichel Azizi, Joost Daemen, Melvin D Lobo, et al.
JACC. Cardiovascular Interventions|July 20, 2019
Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back DataChristopher M Cook, Takayuki Warisawa, James P Howard, et al.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
Nature|June 3, 2026
Nuclear shell structure governs short-range nucleon pairingD Nguyen, C Yero, H Szumila-Vance, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
Circulation|May 24, 2018
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery DiseaseRasha Al-Lamee, James P Howard, Matthew J Shun-Shin, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
European Heart Journal|March 27, 2020
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapiesFelix Mahfoud, Michel Azizi, Sebastian Ewen, et al.
Circulation|September 12, 2024
Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research CollaborativeKenneth Rosenfield, Terry R Bowers, Christopher F Barnett, et al.
Pageof 49